These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23256811)

  • 1. Development of predictive quantitative structure-activity relationship model and its application in the discovery of human leukotriene A4 hydrolase inhibitors.
    Thangapandian S; John S; Son M; Arulalapperumal V; Lee KW
    Future Med Chem; 2013 Jan; 5(1):27-40. PubMed ID: 23256811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore-based virtual screening and Bayesian model for the identification of potential human leukotriene A4 hydrolase inhibitors.
    Thangapandian S; John S; Sakkiah S; Lee KW
    Eur J Med Chem; 2011 May; 46(5):1593-603. PubMed ID: 21377770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design.
    Thangapandian S; John S; Arooj M; Lee KW
    PLoS One; 2012; 7(4):e34593. PubMed ID: 22496831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification and QSAR models of leukotriene A4 hydrolase (LTA4H) inhibitors by machine learning methods.
    Qin R; Wang H; Yan A
    SAR QSAR Environ Res; 2021 May; 32(5):411-431. PubMed ID: 33896285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular docking and pharmacophore filtering in the discovery of dual-inhibitors for human leukotriene A4 hydrolase and leukotriene C4 synthase.
    Thangapandian S; John S; Sakkiah S; Lee KW
    J Chem Inf Model; 2011 Jan; 51(1):33-44. PubMed ID: 21133343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking.
    Audat SA; Al-Shar'i NA; Al-Oudat BA; Bryant-Friedrich A; Bedi MF; Zayed AL; Al-Balas QA
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32580506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses.
    Appiah-Kubi P; Soliman ME
    J Biomol Struct Dyn; 2016 Nov; 34(11):2418-33. PubMed ID: 26555301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR, docking studies and pharmacophore identification of phenylmethyl phenoxy propyl amino propanoic acid derivatives as leukotriene A4 hydrolase inhibitors.
    Sonawane LV; Bari SB
    Yao Xue Xue Bao; 2010 May; 45(5):615-23. PubMed ID: 20931764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid Receptor-Bound/MM-GBSA-Per-residue Energy-Based Pharmacophore Modelling: Enhanced Approach for Identification of Selective LTA4H Inhibitors as Potential Anti-inflammatory Drugs.
    Appiah-Kubi P; Soliman M
    Cell Biochem Biophys; 2017 Mar; 75(1):35-48. PubMed ID: 27914004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Structure Guided QSAR: A Rapid and Accurate technique to predict IC50: A Case Study.
    Mishra RK; Singh J
    Curr Comput Aided Drug Des; 2015; 11(2):152-63. PubMed ID: 26135341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamic properties of leukotriene A
    Wittmann SK; Kalinowsky L; Kramer JS; Bloecher R; Knapp S; Steinhilber D; Pogoryelov D; Proschak E; Heering J
    Bioorg Med Chem; 2016 Nov; 24(21):5243-5248. PubMed ID: 27651294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, docking, cytotoxicity, and LTA
    El-Naggar MH; Mira A; Abdel Bar FM; Shimizu K; Amer MM; Badria FA
    Bioorg Med Chem; 2017 Feb; 25(3):1277-1285. PubMed ID: 28065501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors.
    Numao S; Hasler F; Laguerre C; Srinivas H; Wack N; Jäger P; Schmid A; Osmont A; Röthlisberger P; Houguenade J; Bergsdorf C; Dawson J; Carte N; Hofmann A; Markert C; Hardaker L; Billich A; Wolf RM; Penno CA; Bollbuck B; Miltz W; Röhn TA
    Sci Rep; 2017 Oct; 7(1):13591. PubMed ID: 29051536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive fluorigenic substrate for selective in vitro and in vivo assay of leukotriene A4 hydrolase activity.
    Poras H; Duquesnoy S; Fournié-Zaluski MC; Ratinaud-Giraud C; Roques BP; Ouimet T
    Anal Biochem; 2013 Oct; 441(2):152-61. PubMed ID: 23851339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico modeling of the molecular structure and binding of leukotriene A4 into leukotriene A4 hydrolase.
    Paz PB; Vega-Hissi EG; Estrada MR; Garro Martinez JC
    Chem Biol Drug Des; 2012 Dec; 80(6):902-8. PubMed ID: 22913921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capturing LTA
    Stsiapanava A; Samuelsson B; Haeggström JZ
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9689-9694. PubMed ID: 28827365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents.
    Penning TD
    Curr Pharm Des; 2001 Feb; 7(3):163-79. PubMed ID: 11311111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a homogeneous time-resolved fluorescence leukotriene B4 assay for determining the activity of leukotriene A4 hydrolase.
    Liang AM; Claret E; Ouled-Diaf J; Jean A; Vogel D; Light DR; Jones SW; Guilford WJ; Parkinson JF; Snider RM
    J Biomol Screen; 2007 Jun; 12(4):536-45. PubMed ID: 17384330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and selective inhibitors of leukotriene A4 hydrolase: effects on purified enzyme and human polymorphonuclear leukocytes.
    Wetterholm A; Haeggström JZ; Samuelsson B; Yuan W; Munoz B; Wong CH
    J Pharmacol Exp Ther; 1995 Oct; 275(1):31-7. PubMed ID: 7562564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of inflammatory disease by inhibitors of leukotriene A4 hydrolase.
    Fourie AM
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1173-82. PubMed ID: 19876785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.